Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abid Awisat

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Rambam Maimonides Medical Journal|April 28, 2023
Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and TreatmentAbid Awisat, Shiri Keret, Amal Silawy, et al.
Annals of the Rheumatic Diseases|September 10, 2020
Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review'. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar <i>et al</i>Doron Rimar, Abid Awisat, Lisa Kaly, et al.
Clinical Rheumatology|November 13, 2019
Crowned dens syndrome, yet another rheumatic disease imposterAbid Awisat, Itzhak Rosner, Doron Rimar, et al.
The Israel Medical Association Journal : IMAJ|March 18, 2021
Acute Gout SacroiliitisLisa Kaly, Igor Bilder, Michael Rozenbaum, et al.
Seminars in Arthritis and Rheumatism|September 11, 2016
Autoinflammatory associated vasculitisShira Ginsberg, Itzhak Rosner, Michel Rozenbaum, et al.
Microvascular Research|July 14, 2022
Nailfold video capillaroscopy as a useful diagnostic tool in systemic vasculitisShiri Keret, Jan Mazzawi, Gleb Slobodin, et al.
Rheumatology (Oxford, England)|May 21, 2025
Leg edema in systemic sclerosis: uncovering fasciitis and myositis as key underlying causesShiri Keret, Merav Lidar, Aniela Shouval, et al.
Clinical Rheumatology|April 12, 2019
Infliximab for the treatment of refractory polyarteritis nodosaShira Ginsberg, Itzhak Rosner, Gleb Slobodin, et al.
Annals of the Rheumatic Diseases|August 26, 2016
Tofacitinib for polyarteritis nodosa: a tailored therapyDoron Rimar, Ayelet Alpert, Elina Starosvetsky, et al.
Rheumatology (Oxford, England)|December 9, 2025
Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in systemic sclerosis: a real-world national cohort studyShiri Keret, Shlomit Yaari, Aniela Shouval, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Rambam Maimonides Medical Journal|April 28, 2023
Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and TreatmentAbid Awisat, Shiri Keret, Amal Silawy, et al.
Annals of the Rheumatic Diseases|September 10, 2020
Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review'. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar <i>et al</i>Doron Rimar, Abid Awisat, Lisa Kaly, et al.
Clinical Rheumatology|November 13, 2019
Crowned dens syndrome, yet another rheumatic disease imposterAbid Awisat, Itzhak Rosner, Doron Rimar, et al.
The Israel Medical Association Journal : IMAJ|March 18, 2021
Acute Gout SacroiliitisLisa Kaly, Igor Bilder, Michael Rozenbaum, et al.
Seminars in Arthritis and Rheumatism|September 11, 2016
Autoinflammatory associated vasculitisShira Ginsberg, Itzhak Rosner, Michel Rozenbaum, et al.
Microvascular Research|July 14, 2022
Nailfold video capillaroscopy as a useful diagnostic tool in systemic vasculitisShiri Keret, Jan Mazzawi, Gleb Slobodin, et al.
Rheumatology (Oxford, England)|May 21, 2025
Leg edema in systemic sclerosis: uncovering fasciitis and myositis as key underlying causesShiri Keret, Merav Lidar, Aniela Shouval, et al.
Clinical Rheumatology|April 12, 2019
Infliximab for the treatment of refractory polyarteritis nodosaShira Ginsberg, Itzhak Rosner, Gleb Slobodin, et al.
Annals of the Rheumatic Diseases|August 26, 2016
Tofacitinib for polyarteritis nodosa: a tailored therapyDoron Rimar, Ayelet Alpert, Elina Starosvetsky, et al.
Rheumatology (Oxford, England)|December 9, 2025
Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in systemic sclerosis: a real-world national cohort studyShiri Keret, Shlomit Yaari, Aniela Shouval, et al.
Pageof 3